| Hans-Günter Meyer-Thompson | International
FDA Shutting Down Fentanyl Access Program for Cancer Patients
FDA Shutting Down Fentanyl Access Program for Cancer Patients
The U.S. Food and Drug Administration is shutting down a pain management program that helped supply fentanyl medication to patients suffering from severe cancer pain.
In a notice published on the FDA’s website for its Transmucosal Immediate-Release Fentanyl Medicines (TIRF) program, the agency said that all TIRF medications “will be discontinued” on September 30. (Pain News Network, USA, 12.09.2024)